Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 33.56 Million CHF | 86.61% |
| 2022 | 17.98 Million CHF | 30.19% |
| 2021 | 13.81 Million CHF | 242.04% |
| 2020 | 4.03 Million CHF | 57.71% |
| 2019 | 2.56 Million CHF | 258.18% |
| 2018 | 715 Thousand CHF | 33.9% |
| 2017 | 534 Thousand CHF | -49.67% |
| 2016 | 1.06 Million CHF | -83.3% |
| 2015 | 6.35 Million CHF | 535.5% |
| 2014 | 1 Million CHF | 0.0% |
| 2013 | 1 Million CHF | -9.09% |
| 2012 | 1.1 Million CHF | -29.98% |
| 2011 | 1.57 Million CHF | -92.97% |
| 2010 | 22.34 Million CHF | 145.38% |
| 2009 | 9.1 Million CHF | -53.82% |
| 2008 | 19.72 Million CHF | -45.03% |
| 2007 | 35.88 Million CHF | 4856.08% |
| 2006 | 724 Thousand CHF | -83.39% |
| 2005 | 4.35 Million CHF | 5.98% |
| 2004 | 4.11 Million CHF | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 31.84 Million CHF | 0.0% |
| 2023 Q2 | 12.86 Million CHF | 100.0% |
| 2023 Q1 | 6.43 Million CHF | -14.91% |
| 2023 Q4 | 20.69 Million CHF | 100.0% |
| 2023 Q3 | 10.34 Million CHF | -19.56% |
| 2023 FY | 33.56 Million CHF | 86.61% |
| 2022 Q4 | 7.56 Million CHF | 100.0% |
| 2022 FY | 17.98 Million CHF | 30.19% |
| 2022 Q1 | 5.21 Million CHF | 10.23% |
| 2022 Q2 | 10.42 Million CHF | 100.0% |
| 2022 Q3 | 3.78 Million CHF | -63.74% |
| 2021 Q2 | 9.08 Million CHF | 100.0% |
| 2021 Q1 | 4.54 Million CHF | 65.56% |
| 2021 Q3 | 2.36 Million CHF | -73.98% |
| 2021 Q4 | 4.72 Million CHF | 100.0% |
| 2021 FY | 13.81 Million CHF | 242.04% |
| 2020 Q3 | 1.37 Million CHF | 5.95% |
| 2020 FY | 4.03 Million CHF | 57.71% |
| 2020 Q4 | 2.74 Million CHF | 100.0% |
| 2020 Q1 | 647.5 Thousand CHF | -60.78% |
| 2020 Q2 | 1.29 Million CHF | 100.0% |
| 2019 FY | 2.56 Million CHF | 258.18% |
| 2019 Q2 | 910 Thousand CHF | 100.0% |
| 2019 Q3 | 825.5 Thousand CHF | -9.29% |
| 2019 Q1 | 455 Thousand CHF | 106.35% |
| 2019 Q4 | 1.65 Million CHF | 100.0% |
| 2018 FY | 715 Thousand CHF | 33.9% |
| 2018 Q3 | 220.5 Thousand CHF | 60.95% |
| 2018 Q2 | 137 Thousand CHF | 0.0% |
| 2018 Q4 | 220.5 Thousand CHF | 0.0% |
| 2018 Q1 | 137 Thousand CHF | 0.0% |
| 2017 Q2 | 267 Thousand CHF | 0.0% |
| 2017 Q4 | - CHF | 0.0% |
| 2017 Q1 | 267 Thousand CHF | 8800.0% |
| 2017 Q3 | - CHF | -100.0% |
| 2017 FY | 534 Thousand CHF | -49.67% |
| 2016 Q2 | 527.5 Thousand CHF | 0.0% |
| 2016 Q3 | 3000.00 CHF | -99.43% |
| 2016 FY | 1.06 Million CHF | -83.3% |
| 2016 Q1 | 527.5 Thousand CHF | 825.44% |
| 2016 Q4 | 3000.00 CHF | 0.0% |
| 2015 FY | 6.35 Million CHF | 535.5% |
| 2015 Q4 | 57 Thousand CHF | 0.0% |
| 2015 Q3 | 57 Thousand CHF | 280.0% |
| 2015 Q2 | 15 Thousand CHF | 0.0% |
| 2015 Q1 | 15 Thousand CHF | 0.0% |
| 2014 FY | 1 Million CHF | 0.0% |
| 2013 Q3 | 250 Thousand CHF | 0.0% |
| 2013 Q4 | 250 Thousand CHF | 0.0% |
| 2013 Q2 | 250 Thousand CHF | 0.0% |
| 2013 FY | 1 Million CHF | -9.09% |
| 2013 Q1 | 250 Thousand CHF | 0.0% |
| 2012 Q4 | 250 Thousand CHF | 0.0% |
| 2012 Q1 | 250 Thousand CHF | 0.0% |
| 2012 FY | 1.1 Million CHF | -29.98% |
| 2012 Q2 | 350 Thousand CHF | 40.0% |
| 2012 Q3 | 250 Thousand CHF | -28.57% |
| 2011 Q2 | 389 Thousand CHF | -35.17% |
| 2011 FY | 1.57 Million CHF | -92.97% |
| 2011 Q4 | 250 Thousand CHF | -24.7% |
| 2011 Q3 | 332 Thousand CHF | -14.65% |
| 2011 Q1 | 600 Thousand CHF | -4.76% |
| 2010 Q2 | 21.16 Million CHF | 8367.6% |
| 2010 Q1 | 250 Thousand CHF | -65.03% |
| 2010 Q3 | 300 Thousand CHF | -98.58% |
| 2010 FY | 22.34 Million CHF | 145.38% |
| 2010 Q4 | 630 Thousand CHF | 110.0% |
| 2009 Q1 | 250 Thousand CHF | 0.0% |
| 2009 Q2 | 6.32 Million CHF | 2430.0% |
| 2009 Q4 | 715 Thousand CHF | -60.67% |
| 2009 Q3 | 1.81 Million CHF | -71.26% |
| 2009 FY | 9.1 Million CHF | -53.82% |
| 2008 FY | 19.72 Million CHF | -45.03% |
| 2007 FY | 35.88 Million CHF | 4856.08% |
| 2006 FY | 724 Thousand CHF | -83.39% |
| 2005 FY | 4.35 Million CHF | 5.98% |
| 2004 FY | 4.11 Million CHF | 0.0% |
| Name | Revenue | Revenue Difference |
|---|